Is it time for watchful waiting for rectal cancer?

The Lancet Oncology

Volumn 16, Issue 8, 2015, Pages 875-876

  Breugom, Anne J ^a   van de Velde, Cornelis J H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; CANCER SURGERY; CHEMORADIOTHERAPY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; NOTE; PATIENT CARE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION HAZARD; RECTUM CANCER; SURGICAL RISK; TREATMENT RESPONSE; WATCHFUL WAITING; ADENOCARCINOMA; BRACHYTHERAPY; FEMALE; MALE; PROCEDURES; RECTAL NEOPLASMS;

ANTINEOPLASTIC ANTIMETABOLITE; TEGAFUR;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; BRACHYTHERAPY; CHEMORADIOTHERAPY; FEMALE; HUMANS; MALE; RECTAL NEOPLASMS; TEGAFUR; WATCHFUL WAITING;

EID: 84938211329     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(15)00015-7     Document Type: Note

References (11)

1. Habr-Gama A, de Souza PM, Ribeiro U, et al. Low rectal cancer: impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum 1998, 41:1087-1096.
2. Appelt AL, Pløen J, Harling H, et al. High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. Lancet Oncol 2015, published online July 6. http://dx.doi.org/10.1016/S1470-2045(15)00120-5.
3. Habr-Gama A, Gama-Rodrigues J, Sao Juliao GP, et al. Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. Int J Radiat Oncol Biol Phys 2014, 88:822-828.
4. Maas M, Beets-Tan RG, Lambregts DM, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 2011, 29:4633-4640.
5. Garcia-Aguilar J, Shi Q, Thomas CR, et al. A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial. Ann Surg Oncol 2012, 19:384-391.
6. Heald RJ, Beets G, Carvalho C Report from a consensus meeting: response to chemoradiotherapy in rectal cancer-predictor of cure and a crucial new choice for the patient: on behalf of the Champalimaud 2014 Faculty for 'Rectal cancer: when NOT to operate'. Colorectal Dis 2014, 16:334-337.
7. Braendengen M, Tveit KM, Bruheim K, Cvancarova M, Berglund A, Glimelius B Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study. Int J Radiat Oncol Biol Phys 2011, 81:1017-1024.
8. Lange MM, Martz JE, Ramdeen B, et al. Long-term results of rectal cancer surgery with a systematical operative approach. Ann Surg Oncol 2013, 20:1806-1815.
9. Wiltink LM, Chen TY, Nout RA, et al. Health-related quality of life 14 years after preoperative short-term radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomised trial. Eur J Cancer 2014, 50(14):2390-2398.
10. van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011, 12:575-582.
11. Taylor FG, Quirke P, Heald RJ, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg 2011, 253:711-719.